Therapy Area (482)

Oncology (94)

Prostate, Breast, Lung, Melanoma, Colorectal

Central Nervous System (93)

Neurology, Psychiatry, Pain

Infectious Disease (70)

Viral Infection, Bacterial Infections, Vaccines, Fungal Infections, Parasitic Infections

Immunology and Inflammation (58)

Musculoskeletal, Autoimmune, Dermatology, Transplant

Urology and Gender-Specific Health (43)

Women's Health, Sexual Health, Urology, Male Health

Pharmaceuticals (226)

Pharmaceutical Manufacturers (146)

Branded Prescription Drugs, Generic Prescription Drugs, Over-the-Counter Medicines (OTC), Retail Drug and Consumer Products

Drug Delivery (12)

Delivery Vehicles and Molecules, Physical Devices and Approaches, Administration, PhysioChemical

Pharmaceutical Contract Research Organizations (10)

Clinical Trials Services, Bio Analytical Services

Specialty Pharmaceuticals and Chemicals (5)

Manufacturing Services and Outsourcing (5)

Healthcare (63)

Healthcare Information Technology (2)

Healthcare Distribution (1)

Medical Devices and Diagnostics (41)

Diagnostic Devices and Imaging (3)

Clinical Diagnostics, CNS and Neurological Diagnostics, Imaging

Cardiovascular Devices (2)

Biomaterials and Tissue Regeneration (2)

Respiratory and Anesthesia Devices (2)

Orthopedic Devices (1)

Knee Implants, Hip Implants

Biotechnology (38)

Technology (17)

Enabling Technology, Genomics, Proteomics and Pharmacogenomics, Gene and Cell Therapy, Stem Cells

Manufacturers (2)

Biomanufacturing

Industry

Biotechnology (71)

Healthcare (88)

Medical Devices and Diagnostics (86)

Other (11)

Pharmaceuticals (139)

Therapy Area (112)

Geography

Asia-Pacific (47)

Europe (78)

Middle East and Africa (3)

North America (209)

South and Central America (2)

Number of Employees

< 250 (31)

250 - 999 (23)

1,000 - 2,499 (21)

2,500 - 4,999 (37)

5,000 - 9,999 (57)

10,000 - 49,999 (114)

50,000+ (39)

Annual Revenue US$m

< 50 (22)

50 - 99 (5)

100 - 199 (8)

200 - 499 (25)

500 - 999 (9)

1,000 - 1,999 (50)

2,000+ (192)

Pharmaceuticals (131)

Pharmaceutical Manufacturers (61)

Over-the-Counter Medicines (OTC)

Drug Delivery (22)

Manufacturing Services and Outsourcing (3)

Manufacturing

Specialty Pharmaceuticals and Chemicals (2)

Healthcare (41)

Healthcare Facilities and Providers (2)

Biotechnology (18)

Medical Devices and Diagnostics (12)

Orthopedic Devices (10)

Therapy Area (1)

Immunology and Inflammation (1)

Food Allergy

Top stories

Accentus Medical enters into licensing agreement with Zimmer

Accentus Medical, a UK-based medical technology company, has signed a license and services agreement with Zimmer Holdings, a manufacturer of orthopedic products and instruments...more >>

Bayer wins European approval for erectile dysfunction drug

Bayer Schering Pharma has reported that the European Commission has approved a new formulation of Levitra used for the treatment of erectile dysfunction, or ED...more >>

ThromboGenics reports positive results from Phase III retinal disorder program

ThromboGenics, a Belgian biopharmaceutical company, has reported positive pooled results from the successful microplasmin Mivi-Trust Phase III program, confirming microplasmin's potential to transform the treatment of retinal disorders...more >>

DM and ORF Genetics to collaborate on protein drugs

DM Corporation and ORF Genetics have signed a memorandum of understanding, or MoU, to collaborate on the development, production and marketing of protein drugs...more >>

More headlines

Celldex to regain worldwide rights to develop rindopepimut
Published 06 September 2010 - Datamonitor

Alcon launches AcrySof IQ ReSTOR intraocular lens outside US
Published 06 September 2010 - Datamonitor

Tibotec files European marketing authorization application for HIV drug
Published 06 September 2010 - Datamonitor

CBio completes enrollment in Phase II rheumatoid arthritis trial
Published 06 September 2010 - Datamonitor

Bausch + Lomb appoints new corporate vice president of human resources
Published 06 September 2010 - Datamonitor

Emerald BioStructures and SomaLogic form strategic collaboration
Published 06 September 2010 - Datamonitor

Agennix reports positive results from Phase II sepsis trial
Published 06 September 2010 - Datamonitor

Novartis and partners develop new malaria drug
Published 06 September 2010 - Datamonitor

CSI to establish new cancer diagnostics facility in Atlanta, Georgia
Published 06 September 2010 - Datamonitor

Bausch + Lomb to acquire Miochol-E from Novartis
Published 06 September 2010 - Datamonitor

Miraculins completes acquisition of Prevu(i) skin cholesterol test from PreMD
Published 06 September 2010 - Datamonitor

Browse all news >>